Approved by the Board on: 21 December 2016
1. Notes the Secretariat's review of the items on the 2014 - 2016 allocation period's unfunded quality demand ("UQD") register, as described GF/B36/ER04;
2. Approves the additional incremental funding recommended for certain UQD of the following country disease components: (i) Bangladesh TB, (ii) Central African Republic TB/HIV, (iii) Myanmar TB, (iv) Philippines TB, and (v) Viet Nam TB, as listed in Table 4 of Section IV to GF/B36/ER04, based on the available funding that the FOPC validated pursuant to GF/FOPC17/DP02;
3. Affirms the additional incremental funding approved under this decision (a) increases the upper-ceiling amount that may be available for the relevant implementation period of each country disease component's constituent grants, (b) is subject to the availability of funding, and (c) shall be committed in annual tranches; and
4. Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the "TRP") validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.
See attached table detailing total recommended funding amount for the following grants: BGD-TBRAC, BGD-TNTP, CAF-CIFRC, PHL-TPBSP, VNM-TNTP, MYN-TSCF, MYN-TUNOPS. More on Funding Decisions.